CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naive Cancer Patients

Geundoo Jang, Hun Ho Song, Keon Uk Park, Hyeong Su Kim, Dae Ro Choi, Jung Hye Kwon, Ho Young Kim, Boram Han, Jung Han Kim, Joo Young Jung, Hyo Jung Kim, Dae Young Zang

Cancer Research and Treatment. 2013;45(3):172-177. Published online 2013 September 30 DOI: https://doi.org/10.4143/crt.2013.45.3.172

A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naive Cancer Patients

Geundoo Jang, Hun Ho Song, Keon Uk Park, Hyeong Su Kim, Dae Ro Choi, Jung Hye Kwon, Ho Young Kim, Boram Han, Jung Han Kim, Joo Young Jung, Hyo Jung Kim, Dae Young Zang

Cancer Research and Treatment. 2013;45(3):172-177

Link1

Link2

Editorial Comment to Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients

Antonio Rozzi, Gaetano Lanzetta

International Journal of Urology. 2015;22(10):915-915

Link1 Link2

Palonostron with Aprepitant–Dexamethasone to Prevent Chemotherapy-Induced Nausea and Vomiting During Gemcitabine/Cisplatin in Urothelial Cancer Patients

H. Kitamura, F. Fukuta, N. Nishiyama, T. Tanaka, N. Masumori, T. Tsukamoto

Annals of Oncology. 2012;23:xi142

Link1 Link2

Safety and efficacy of aprepitant for chemotherapy-induced nausea and vomiting in pediatric patients: A prospective, observational study

Megan Bodge, Alexandra Shillingburg, Stephan Paul, Lisa Biondo

Pediatric Blood & Cancer. 2013;61(6):1111-1113

Link1 Link2

Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial

Nobuhiro Takeshima, Maki Matoda, Masakazu Abe, Yasuyuki Hirashima, Kentaro Kai, Kaei Nasu, Masashi Takano, Kenichi Furuya, Seiya Sato, Hiroaki Itamochi, Hiroshi Tsubamoto, Kosei Hasegawa, Kiminari Terao, Takeo Otsuki, Keiko Kuritani, Kimihiko Ito

Supportive Care in Cancer. 2014;22(11):2891-2898

Link1

Link2 Link3

A randomized phase II study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy

W. Yeo, F.K.F. Mo, J.J.S. Suen, W.M. Ho, S.L. Chan, W.K. Yeung, W. Lau, K.K.C. Lee, W.H. Kwan, B. Zee

European Journal of Cancer Supplements. 2008;6(7):198

Link1 Link2

Aprepitant, Granisetron and Dexamethasone Versus Palonosetron and Dexamethasone for Cisplatin-Induced Nausea and Vomiting in Patients with Upper Gastrointestinal Cancer: a Randomized Crossover Phase Ii Trial (Kdog 1002)

K. Ishido, K. Higuchi, M. Azuma, T. Sasaki, S. Tanabe, C. Katada, W. Koizumi

Annals of Oncology. 2014;25:iv521

Link1 Link2 Link3

3079 POSTER 3-day Aprepitant Plus Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving Cisplatin-based Chemotherapy

S.J. Svm, J. Hong, M. Jung, J. Park, E.K. Cho, J.H. Lee, D.B. Shin

European Journal of Cancer. 2011;47:S245

Link1 Link2

Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial

Masakazu Abe, Yasuyuki Hirashima, Yuka Kasamatsu, Nobuhiro Kado, Satomi Komeda, Shiho Kuji, Aki Tanaka, Nobutaka Takahashi, Munetaka Takekuma, Hanako Hihara, Yoshikazu Ichikawa, Yui Itonaga, Tomoko Hirakawa, Kaei Nasu, Kanoko Miyagi, Junko Murakami, Kimihiko Ito

Supportive Care in Cancer. 2015;24(2):675-682

Link1

Link2 Link3

Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy

Takeshi Ioroi, Junya Furukawa, Manabu Kume, Sachi Hirata, Yuko Utsubo, Naomi Mizuta, Hideaki Miyake, Masato Fujisawa, Midori Hirai

Supportive Care in Cancer. 2017;

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.